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Does Free Cell Area Influence the Outcome in Carotid Artery Stenting?
Bosiers M., de Donato G., Deloose K., Verbist J., Peeters P., Castriota F.,
Cremonesi A., Setacci C. Eur J Vasc Endovasc Surg 33:135-41.
Objectives To identify if carotid stent design, especially free cell area,
impacts on the 30-day rates for stroke, death and TIA after carotid artery
stenting (CAS).
Material and methods A CAS database of 3179 consecutive CAS
patients was retrospectively assessed. The distribution of neurological com-
plications were analysed for association with the different stent types and
designs. Events where subdivided into procedural and postprocedural
events.
Results The overall combined rate of TIA, stroke and death was 2.8%
at 30 days (late events 1.9%). The post-procedural event rate analyzed for
differences stents varied from 1.2% using BSCI Carotid Wallstent to 5.9%
using Medtronic Exponent. The late event rates varied from 1.2% to 3.4% for
free cell areas 2.5 mm2 and 7.5 mm2 respectively (p0.05). Post-
procedural event rate was 1.3% for closed cells and 3.4% for open cells. All
these differences were highly pronounced among symptomatic patients
(p0.0001).
Conclusions After carotid stenting, complication rates vary according
to stent type, free cell area and cell design. In the symptomatic population
(and also in the total population), post-procedural complication rates are
highest for the open cell types and increase with larger free cell area.
Homocysteine and Early Re-stenosis After Carotid Eversion
Endarterectomy
Assadian A., Rotter R., Assadian O., Senekowitsch C., Hagmüller G.W.,
Hübl W. Eur J Vasc Endovasc Surg 33:144-8.
Background Homocysteine (Hcy) appears to be involved in the de-
velopment of intimal hyperplasia and arterial thrombosis. The purpose of
this study was to evaluate the association of plasma Hcy with early re-stenosis
following carotid eversion endarterectomy.
Patients andmethodsOf 398 consecutive patients, 363 were included
in this study. 62% of patients had symptomatic internal carotid artery (ICA)
stenosis. Patients had preoperative assessment of Hcy and other well estab-
lished atherosclerosis risk factors. Intraoperatively, completion angiography
was performed in 2 planes. Patients had clinical, Hcy and duplex follow up at
1, 3, 18 and 36 months postoperatively.
Results Complete follow up data were available for 312 patients.
Five patients suffered from strokes and 2 patients died during the
peri-operative period (combined stroke and death rate of 2%). Mean
follow up was 265 months (range 17 to 36 months). Seventeen and six
patients (5.5%) developed a 50-69% and 70% re-stenosis, respectively.
Serum creatinine was significantly higher in patients with early
re-stenosis, occlusion or stroke after CEA (P0.043). High grade
re-stenosis, occlusion and stroke ipsilateral to the operated side (17
patients) was associated with HbA1C and creatinine (P0.043 and
0.046, respectively) but not Hcy.
Conclusion While Hcy is a recognized independent risk factor for
atherothrombosis, our study suggests that there is no association of Hcy
with early re-stenosis after eversion endarterectomy.
Systematic Review and Meta-analysis of 12 Years of Endovascular
Abdominal Aortic Aneurysm Repair
Franks S.C., Sutton A.J., Bown M.J., Sayers R.D. Eur J Vasc Endovasc Surg
33:154-71.
Background Endovascular repair (ER) of abdominal aortic aneurysm
(AAA) is a new technique, and reported rates of endoleak, conversion to
open repair, rupture and mortality vary widely. The aim of this study was to
estimate these rates from the published data, and examine how this has
changed as more patients have undergone ER.
Methods A systematic review and meta-analysis of publications iden-
tified through searches of the electronic databases EMBASE and Medline.
All publications quoting endoleak, conversion to open repair, rupture and
mortality rates for a series of patients undergoing ER were included.
Results 163 studies pertaining to 28,862 patients undergoing ER were
identified as relevant for the review and meta-analysis. The pooled estimate
for operative mortality was 3.3% (95% confidence interval 2.9 to 3.6%). The
pooled estimate for type 1 endoleaks was 10.5% (95% confidence interval 9.0
to 12.1%), with an annual rate of 8.4% (95% confidence interval 5.7% to
12.2%). The pooled estimate of type 2,3 and 4 endoleaks was 13.7% (95%
confidence interval 12.3 to15.3%), with an annual rate of 10.2% (95%
confidence interval 7.4% to 14.1%). The pooled estimate for primary con-
version to open repair was 3.8% (95% confidence interval 3.2 to 4.4%), and
for secondary conversion to open repair 3.4% (95% confidence interval 2.8 to
4.2%). The pooled estimate for post-operative rupture was 1.3% (95%
confidence interval 1.1 to 1.7%), with an annual rupture rate of 0.6% (95%
confidence interval 0.5% to 0.8%). Multivariate meta-regression analysis
showed that rates of operative mortality, post-operative rupture and total
number of endoleaks all fell significantly (p0.05) over time.
Conclusions This study demonstrates a low mortality and a gradual
reduction in vascular morbidity and mortality associated with endovascular
repair since it was first introduced.
Impact of Study Design on Outcome after Endovascular Abdominal
Aortic Aneurysm Repair. A Comparison between the Randomized
Controlled DREAM-trial and the Observational EUROSTAR-registry
Leurs L.J., Buth J., Harris P.L., Blankensteijn J.D. Eur J Vasc Endovasc Surg
33:172-6.
Background Patients with abdominal aortic aneurysm (AAA) can be
treated by transfemoral endovascular intervention and by conventional open
surgery. Level-one evidence of the safety and efficacy of one treatment mode
over the other is only provided by a randomised controlled trial (RCT).
Results reported by voluntary registries are considered less valid than data
from RCTs. On the other hand the outcome of a RCT may not be
generalisable to the common practice because of vigorous selection of
patients and institutions.
Purpose The outcomes reported by the Dutch Randomized Endovas-
cular Aneurysm Management (DREAM) trial were compared with the
results of the EURopean collaborators on Stent-graft techniques for AAA
Repair (EUROSTAR) registry.
Methods To obtain comparable study groups with regard to risk
factors equal proportions of ASA I, II and III patients as observed in the
endovascular arm of the DREAMtrial were selected at random from the
EUROSTAR-registry. All patients had an aneurysm of at least 50 mm. Only
patients, who had been enrolled into the registry from 1999, were selected
to avoid the influence of first generation endografts which are not longer in
use. Patient characteristics and outcomes of endovascular AAA repair
(EVAR) of EUROSTAR and DREAM-trial participants were compared.
Differences in early findings between study groups were assessed by Chi-
Square tests for discrete variables and by Wilcoxon rank sum tests for
continuous variables. Follow-up variables were analysed by Kaplan-Meier
and Cox proportional hazard models.
Results Data of 177 patients of the DREAM trial with randomiza-
tion to EVAR and 856 patients selected in the EUROSTAR-registry
were compared. Baseline characteristics were comparable between the
EUROSTAR-cohort and EVAR-arm of the DREAM-trial. The 36-month
survival-rate was 87.6% for EVAR-arm in the DREAM-trial similar to the
86.8% found in this EUROSTAR-study population. The freedom of second-
ary procedures reached after 3 years 85.7%, and 86.9% in the DREAM and
EUROSTAR-cohort, respectively.
Conclusion We found comparable characteristics and outcomes be-
tween patients of comparable risk class of the EUROSTAR-registry and the
EVAR-cohort of the DREAM-trial. This demonstrates the following: first,
the EUROSTAR-data provide reliable information, and further compari-
sons of registry data with patients treated by conventional AAA surgery may
be justified. Secondly, the various outcomes of the randomised DREAM trial
appear generalisable, as it agrees with observations in a broad common
practice derived database.
ANon-randomised Controlled Trial of the Clinical and Cost Effective-
ness of a Supervised Exercise Programme for Claudication
Lee H.L.D., Mehta T., Ray B., Heng M.S.T., McCollum P.T., Chetter I.C.
Eur J Vasc Endovasc Surg 33:202-7.
Objectives The main aims of treatment in patients with intermittent
claudication (IC) are to improve the clinical indicators of lower limb
ischaemia and patients’ quality of life (QoL). The aims of this study were
assess the clinical and cost effectiveness of a supervised exercise programme
(SEP) in patients with IC.
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